Condition
CLN6
Total Trials
3
Recruiting
0
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 1 (1)
Trial Status
Active Not Recruiting2
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07582484Phase 1Not Yet RecruitingPrimary
Gene Therapy Trial for CLN6 Batten Disease
NCT04273243Active Not RecruitingPrimary
Long-Term Follow Up of CLN6 Batten Disease Subjects Following Gene Transfer
NCT03285425Active Not Recruiting
Natural History of Neuronal Ceroid Lipofuscinosis, Batten's CLN6 Diseae
Showing all 3 trials